China Researchers Create First Embryonic-Type Stem Cells From Pig
This article was originally published in PharmAsia News
Executive Summary
Chinese scientists say they have been able to use somatic cells from a pig that are similar to embryonic stem cells, using research that could lead to models for human genetic diseases. The Chinese Academy of Sciences team said its work is the first of its kind, changing somatic cells from an ungulate to behave as embryonic ones. Other stem cells come from sperm or egg cells. The induced pluripotent stem cells were created by reprogramming cells taken from a pig's ear and bone marrow. (Click here for more
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.